Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Indose is a medical technology company that developed the world's first precision-dosing vaporizer for inhalable compounds. The company's platform utilizes advanced sensor technology to measure the density and flow of vapor in real-time, allowing users to see exactly how many milligrams of active ingredients they are consuming. By providing metered dosing and clinical-grade accuracy, Indose aims to standardize the delivery of cannabinoids and other therapeutic inhalables. The technology addresses a critical gap in the medical cannabis market by offering a predictable and repeatable user experience. In 2021, the company was acquired by Green Thumb Industries (GTI), a leading national cannabis consumer packaged goods company. The acquisition allowed GTI to integrate Indose's proprietary hardware into its diverse product portfolio to serve both medical and adult-use markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Indose.